Induction of the fatty acid 2-hydroxylase (FA2H) gene by Δ9-tetrahydrocannabinol in human breast cancer cells

Journal of Toxicological Sciences

Volumn 38, Issue 2, 2013, Pages 305-308

  Takeda, Shuso ^a   Harada, Mari ^a   Su, Shengzhong ^b   Okajima, Shunsuke ^a   Miyoshi, Hiroko ^a   Yoshida, Kazutaka ^a   Nishimura, Hajime ^a   Okamoto, Yoshiko ^a   Amamoto, Toshiaki ^c   Watanabe, Kazuhito ^d   Omiecinski, Curtis J ^b   Aramaki, Hironori ^a  

^a DAIICHI UNIVERSITY OF PHARMACY   (Japan)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c NEUES Corporation   (Japan)

^d HOKURIKU UNIVERSITY   (Japan)

Author keywords

Differentiation; Fatty acid 2 hydroxylase; Human breast cancer cells; Ppar

Indexed keywords

ALKANE 1 MONOOXYGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; TETRAHYDROCANNABINOL;

ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA MICROARRAY; FATTY ACID 2 HYDROXYLASE GENE; GENE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84875487849     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.38.305     Document Type: Article

References (11)

1. Aramaki, H., Tomiyasu, N., Yoshimura, H. and Tsukamoto, H. (1968): Forensic chemical study on marihuana. I. A detection method of the principal constituents by thin-layer and gas chromatographies. Chem. Pharm. Bull. (Tokyo), 16, 822-826.
2. Conzen, S. D. (2008): Minireview: nuclear receptors and breast cancer. Mol. Endocrinol., 22, 2215-2228.
3. Hama, H. (2010): Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. Biochim. Biophys. Acta, 1801, 405-414.
4. Hwang, G.W., Lee, J.Y., Ryoke, K., Matsuyama, F., Kim, J.M., Takahashi, T. and Naganuma, A. (2011): Gene expression profiling using DNA microarray analysis of the cerebellum of mice treated with methylmercury. J. Toxicol. Sci., 36, 389-391.
5. 9-tetrahydrocannabinol mediated by peroxisome proliferatoractivated receptor gamma. Biochem. Biophys. Res. Commun., 337, 824-831.
6. 2. Pharmacol. Rev., 62, 588-631.
7. Peters, J.M., Shah, Y.M. and Gonzalez, F.J. (2012): The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat. Rev. Cancer, 12, 181-195.
8. Takeda, S., Misawa, K., Yamamoto, I. and Watanabe, K. (2008): Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug Metab. Dispos., 36, 1917-1921.
9. Takeda, S., Matsuo, K., Yaji, K., Okajima-Miyazaki, S., Harada, M., Miyoshi, H., Okamoto, Y., Amamoto, T., Shindo, M., Omiecinski, C.J. and Aramaki H. (2011): (-)-Xanthatin selectively induces GADD45γ and stimulates caspase-independent cell death in human breast cancer MDA-MB-231 cells. Chem. Res. Toxicol., 24, 855-865.
10. Tontonoz, P., Hu, E. and Spiegelman, B.M. (1994): Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms. Cell, 79, 1147-1156.
11. Toyama, T., Yoshida, E., Shinkai, Y. and Kumagai, Y. (2011): DNA microarray analysis of human neuroblastoma SH-SY5Y cells exposed to methylmercury. J. Toxicol. Sci., 36, 843-845.